Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.650
+0.020 (0.76%)
At close: Aug 25, 2026, 4:00 PM EDT
2.620
-0.030 (-1.13%)
Pre-market: Aug 26, 2026, 6:09 AM EDT

CervoMed Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-30.35-26.97-16.29-2.17-5.8-4.14
Loss (Gain) From Sale of Investments
-0.46-0.85-1.21---
Stock-Based Compensation
1.31.451.410.410.460.96
Other Operating Activities
----5.422.39-0.9
Change in Accounts Payable
-1.11-0.070.850.570.08-0.15
Change in Other Net Operating Assets
2.632.99-1.29-0.830.30.1
Operating Cash Flow
-27.98-23.45-16.53-7.45-2.57-4.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
23.1918.1-28.66---
Investing Cash Flow
23.1918.1-28.66---

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----6
Net Debt Issued (Repaid)
-----6
Issuance of Common Stock
18.934.5946.40.81--
Other Financing Activities
---10.34--
Financing Cash Flow
18.934.5946.411.15-6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
14.14-0.761.213.7-2.571.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-16.29-13.31-10.69-4.73-1.33-
Unlevered Free Cash Flow
-16.29-13.31-10.69-4.73-1.33-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.532.92-0.44-0.260.38-0.06
SEC Filings: 10-K · 10-Q